Read on Twitter
NOVACYT
The mcap unlock will come.
This stuff doesn't happen in a day. #NCYT has the revenues, it just needs the forward looking non-covid statements to let the share price go with a normal PE ratio
#ALNOV #NVYTF https://twitter.com/gggg2120/status/1347926328289406983
The mcap unlock will come.
This stuff doesn't happen in a day. #NCYT has the revenues, it just needs the forward looking non-covid statements to let the share price go with a normal PE ratio
#ALNOV #NVYTF https://twitter.com/gggg2120/status/1347926328289406983
On the 29th September Novacyt closed at 525p after announcing a £150mil deal. Potentially much more, but that's what is understood to have been triggered.
So.
So.
After over 3 months of silence on revenues and deals, this AIM stock has not only held that price.
But sits today around 826p.
But sits today around 826p.
Novacyt has taken a kicking with the vaccine news and a large profit taking selloff in Q4.
Yet this share still holds over 800p with months of silence.
Yet this share still holds over 800p with months of silence.
What stock does that?
One that 'sentiment has left'?
One that 'sentiment has left'?
Novacyt may not have momentum right now, but if you think this is what 'poor' Novacyt sentiment looks like.
Then you're about to get a reminder of what 'good' Novacyt sentiment looks like.
Then you're about to get a reminder of what 'good' Novacyt sentiment looks like.
Everyone with a clue knows this is the killer testing stock amongst PIs. Even those in 'rival' tickers.
It's plainly obvious. It's fact. II's are needed to take this up and invest long term now. They will come on actual news.
It's plainly obvious. It's fact. II's are needed to take this up and invest long term now. They will come on actual news.
Us PI's can't help there.
But that time is coming. Mullis holds the Aces. Revenues and MidCap growth plans.
He said at AGM more will be revealed on future plans.
But that time is coming. Mullis holds the Aces. Revenues and MidCap growth plans.
He said at AGM more will be revealed on future plans.
Frustrated? Fine.
Understand that. But this share price is amazing for the massive kicking it's gotten lately. The market isn't efficient in the short term.
But it is over longer periods.
Understand that. But this share price is amazing for the massive kicking it's gotten lately. The market isn't efficient in the short term.
But it is over longer periods.
And news, actual set-in-stone revenue news is dropping shortly. No way around that. Mullis will reveal at least one Ace in January - and that's what will kickstart the rally.
And that's if a tender or other deal doesn't land first.
And that's if a tender or other deal doesn't land first.
I agree there is uncertainty.
I disagree that sentiment is not with Novacyt. If it wasn't - with all this vaccine news and mis-information going around on PCR testing, we'd be lower than where we were 3 months back when we had some figures.
I disagree that sentiment is not with Novacyt. If it wasn't - with all this vaccine news and mis-information going around on PCR testing, we'd be lower than where we were 3 months back when we had some figures.
Just a thought, but when this goes, it will properly go.
Take no-one's word for it.
Look at the chart yourself.
Look after the £150 million deal dropped and see for yourself what happens when big numbers get revealed.
Take no-one's word for it.
Look at the chart yourself.
Look after the £150 million deal dropped and see for yourself what happens when big numbers get revealed.
